UHS Q3 2023 Earnings Report
Key Takeaways
Universal Health Services, Inc. reported a net income attributable to UHS of $167.0 million, or $2.40 per diluted share, for Q3 2023, compared to $182.8 million, or $2.50 per diluted share, for Q3 2022. Net revenues increased by 6.8% to $3.563 billion. Adjusted net income attributable to UHS was $177.5 million, or $2.55 per diluted share, compared to $185.8 million, or $2.54 per diluted share, for the same period last year.
Net revenues increased by 6.8% to $3.563 billion.
Net income attributable to UHS was $167.0 million, or $2.40 per diluted share.
Adjusted net income attributable to UHS was $177.5 million, or $2.55 per diluted share.
The company repurchased 1.32 million shares at an aggregate cost of approximately $175.1 million.
UHS
UHS
UHS Revenue by Segment
Forward Guidance
This press release contains forward-looking statements based on current management expectations. Numerous factors may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially.
Positive Outlook
- Gaining or building high quality hospitals in rapidly growing markets.
- Investing in the people and equipment needed to allow each facility to thrive.
- Becoming the leading healthcare provider in each community we serve.
Challenges Ahead
- Nationwide shortage of nurses and other clinical staff and support personnel has been a significant operating issue.
- The impact of the COVID-19 pandemic has had a material effect on our operations and financial results.
- A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs.
- The increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms.
Revenue & Expenses
Visualization of income flow from segment revenue to net income